No Data
No Data
Ironwood Pharmaceuticals Inc (IRWD) Q2 2024 Earnings Call Highlights: Strong LINZESS Demand ...
Capital One Financial Downgrades Ironwood Pharmaceuticals(IRWD.US) to Hold Rating, Cuts Target Price to $5
Ironwood Pharmaceuticals: Balancing Financial Flexibility Against Revenue Challenges and High Debt
The Market Doesn't Like What It Sees From Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Revenues Yet
Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Announces Target Price $12
JMP Securities Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Maintains Target Price $23
No Data
No Data
Jimmy1819 : have you been investing professionally or as a hobby?